title: [Detection of leptospira by culture of vitreous humor and detection of antibodies against leptospira in vitreous humor and serum of 225 horses with equine recurrent uveitis].
abstract: In the ongoing discussion regarding the aetiopathogenesis of equine recurrent uveitis (ERU) it was the aim of the present study to elucidate the relationship of leptospira infection and ERU. In a population of 225 horses leptospira were examined in vitreous humor by culture and leptospira antibody were detected in vitreous humor and serum samples. Preoperative serum samples were collected from 221/225 ERU patients of different age, gender and breed. Undiluted vitreous humor was aseptically taken from 198/225 patients that underwent pars plana vitrectomy at the beginning of surgery and from 27/225 patients' eyeball after enucleation: Serum and vitreous humor were tested for specific leptospiral antibodies by microscopic agglutination test (MAT). Furthermore, vitreous humor was examined by culture. 20 patients which were euthanized due to a live-threatening disease other than ERU served as a control group. A total of 127/221 (57.5%) horses had serum antibodies (≥ 1:100). Most frequently antibodies against L. interrogans serovar Grippotyphosa were detected (79/127), followed by L. interrogans serovar lcterohaemorrhagiae (34/127) and L. interrogans serovar Bratislava (29/127). Only 79/225 horses (35.1%) had leptospiral antibodies in vitreous humor, in which L. interrogans serovar Grippotyphosa (67/79) was identified most frequently followed by L. interrogans serovar Pomona (18/79) and L. interrogans serovar lcterohaemorrhagiae (8/79) which was identified as single or multiple reaction. Isolation of leptospira from vitreous humor was positive in 34/212 horses (16%). 10/20 control horses had a positive antibody titer against leptospira in serum and 2/20 horses in vitreous humor, whereas there was no leptospira detected in culture. The result of 84% negative cultures from vitreous humor of 212 ERU patients is decisive for the diagnosis and therapy of ERU.
authors.forename: Elisa
authors.initials: E
authors.lastname: Dorrego-Keiter
authors.forename: József
authors.initials: J
authors.lastname: Tóth
authors.forename: Lieke
authors.initials: L
authors.lastname: Dikker
authors.forename: Jutta
authors.initials: J
authors.lastname: Sielhorst
authors.forename: Gerald Fritz
authors.initials: GF
authors.lastname: Schusser
mesh_terms: D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D006734:Horse Diseases / Q000276:immunology / Q000382:microbiology*; D006736:Horses; D007919:Leptospira / Q000302:isolation & purification*; D007922:Leptospirosis / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D011446:Prospective Studies; D012008:Recurrence; D014605:Uveitis / Q000276:immunology / Q000382:microbiology / Q000662:veterinary*; D014822:Vitreous Body / Q000382:microbiology*
chemical_list: D000907:Antibodies, Bacterial